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For this volume we have invited authors who have been dealing with various aspects of contrast media toxicity. A wide array of topics are discussed in this special issue, including molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media; the considerable difference among iodinated contrast agents with regard to their osmolality and viscosity and the potential role of their osmolality and viscosity in the pathophysiology of CIN; the changes of renal hemodynamics as well as the renal tubular changes induced by iodinated contrast media; the crucial role of reactive oxygen species in causing CIN; and the role of intracellular Ca 2+ and Na + /Ca 2+ exchanger in the pathogenesis of CIN. Neither diabetes [10] nor multiple myeloma [11] per se can be considered main risk factors, but the important role of associated renal insufficiency and other clinical conditions in predisposing to CIN is discussed in depth. The current evidence on ACE-I/ARB therapy for patients undergoing procedures involving use of contrast media is also reviewed. The quest to find new strategies to prevent CIN has led to a recent clinical study suggesting the use of tocopherol [12] . In this special issue, there are also articles discussing the protective role against CIN of either isotonic sodium chloride solution or isotonic sodium bicarbonate solution, and nonpharmacological as well as pharmacological strategies for prevention of CIN. Finally, in one article the potential role of MBL (mannose-binding lectin, a pattern recognition protein of the lectin pathway of complement) in the pathogenesis of human CIN and the beneficial effects we may obtain in clinical practice by its 
